SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-23-059514
Filing Date
2023-05-12
Accepted
2023-05-12 09:44:46
Documents
2
Period of Report
2023-05-11

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2315549-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2315549-1_3seq1.xml 3 1638
2 EXHIBIT 24 tm2315549d1_ex24.htm EX-24 6563
  Complete submission text file 0001104659-23-059514.txt   9711
Mailing Address C/O ESPERION THERAPEUTICS, INC. 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address
Glickman Mark A (Reporting) CIK: 0001441461 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37809 | Film No.: 23913603

Mailing Address 200 BERKELEY ST. FL 19 BOSTON MA 02116
Business Address 200 BERKELEY ST. FL 19 BOSTON MA 02116 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Issuer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations